NASDAQ
Arena Pharmaceuticals, Inc. (ARNA) has a price/sales ratio of 94260.09x as of Friday, May 22, 2026. This represents a 2724.73% increase compared to its 12-month average of 3336.96x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.